SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-006746
Filing Date
2017-11-08
Accepted
2017-11-08 15:14:11
Documents
47
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_110817p.htm 10-Q 564780
2 EXHIBIT 10.1 exh_101.htm EX-10.1 892
3 EXHIBIT 31.1 exh_311.htm EX-31.1 9487
4 EXHIBIT 31.2 exh_312.htm EX-31.2 9423
5 EXHIBIT 32.1 exh_321.htm EX-32.1 3717
6 EXHIBIT 32.2 exh_322.htm EX-32.2 3551
13 GRAPHIC exh101_01.jpg GRAPHIC 342159
14 GRAPHIC exh101_02.jpg GRAPHIC 189613
  Complete submission text file 0001171843-17-006746.txt   4691907

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE bcrx-20170930.xml EX-101.INS 740549
8 XBRL SCHEMA FILE bcrx-20170930.xsd EX-101.SCH 47457
9 XBRL CALCULATION FILE bcrx-20170930_cal.xml EX-101.CAL 38180
10 XBRL DEFINITION FILE bcrx-20170930_def.xml EX-101.DEF 338403
11 XBRL LABEL FILE bcrx-20170930_lab.xml EX-101.LAB 318537
12 XBRL PRESENTATION FILE bcrx-20170930_pre.xml EX-101.PRE 344198
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 171186324
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1